 The tertiary objective of this study will be to examine the effects of dramatically reducing low-density lipoproteins cholesterol in patients with diabetic macular edema and elevated serum lipid levels. Change vision and retinal thickness will be compared across three groups; 1 patients without elevated serum lipids at baseline, 2 patients with elevated lipid levels at baseline and receive standard of care treatment, and 3 patients with elevated lipid levels at baseline and are aggressively treated pharmacologically. 